Susan Clement Davies
Direttore/Membro del Consiglio presso SCANCELL HOLDINGS PLC
Profilo
Susan Elizabeth Clement Davies is currently an Independent Non-Executive Director at Science Group Plc, a Non-Executive Director at Scancell Holdings Plc, and an Independent Director at MiNA Therapeutics Ltd.
She is also a Non-Executive Director at Exploristics Ltd.
In the past, she worked as a Managing Director in Equity Capital Markets at Citigroup Global Markets Ltd.
She was also an Independent Non-Executive Director at Evgen Pharma Plc and a Managing Director at Torreya Partners LLC.
Ms. Clement Davies has a graduate degree from the London School of Economics & Political Science and an undergraduate degree from University College London.
Posizioni attive di Susan Clement Davies
Società | Posizione | Inizio |
---|---|---|
SCANCELL HOLDINGS PLC | Direttore/Membro del Consiglio | 24/09/2020 |
SCIENCE GROUP PLC | Direttore/Membro del Consiglio | 18/05/2022 |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 01/01/2022 |
Exploristics Ltd. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Susan Clement Davies
Società | Posizione | Fine |
---|---|---|
THERACRYF PLC | Direttore/Membro del Consiglio | 31/12/2023 |
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2018 |
Citigroup Global Markets Ltd.
Citigroup Global Markets Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets. | Corporate Officer/Principal | 01/01/2018 |
Formazione di Susan Clement Davies
University College London | Undergraduate Degree |
London School of Economics & Political Science | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
THERACRYF PLC | Health Services |
SCANCELL HOLDINGS PLC | Health Technology |
SCIENCE GROUP PLC | Commercial Services |
Aziende private | 4 |
---|---|
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Finance |
Citigroup Global Markets Ltd.
Citigroup Global Markets Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets. | Finance |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Health Technology |
Exploristics Ltd. |
- Borsa valori
- Insiders
- Susan Clement Davies